Category Archives: Cancer

Home / Cancer
2 Posts

It is a weekly international, peer-reviewed journal that focuses on the research on aspects of oncology. The paper was established in 2010 and is printed by impact journals.

Which Areas does the Journal Cover?

It deals with a potential target for therapy and the procedures to be followed to improve cancer patients management. Also, it focuses on the implication of the management programs, new therapeutic agents, and the protocols on the patient perceptive, which include adherence, quality of life, and their overall satisfaction.

The paper explains and explores the evidence behind existing and the new therapies in terms of outcome improvement. It, most importantly, defines their usage in terms of acceptance and ultimate uptake by the pre-existing, new patient, and healthcare professionals.

What are the Advantages of Publishing in Oncotargets?

The paper is available to anyone since it is an open access document. It can be downloaded for free from dove websites. This allows discoveries to be shared quickly. The papers sent to them are never rejected due to lack of space, unlike many international traditional journals. It is electronic and, therefore, there is no limit to the number of papers that they can choose to publish.

In many journals, the time taken from submission to decision-making is about a month, Mikhail Blagosklonny which is frustrating to the authors. Oncotargets, however, is the fastest article to follow the process. A peer review is complete with two days and editor decisions made within five days of a submission. It is only in rare situations that you may wait for a month for a final decision to be made.

Many authors around the world have found that the peer review comments to be true, and in most cases, they add to their final paper. The paper, therefore, helps researchers contribute highly to the progress of science.

To know more visit @:

For most people, cancer is a frightening diagnosis that is fraught with confusion. For Eric Lefkofsky, it was eye-opening. When Eric Lefkofsky wife, Elizabeth, was diagnosed with cancer, he realized just how difficult it is for patients and their families to understand what is going on and how best to combat their disease. Eric Lefkofsky decided to come up with a solution. He joined forces with Brad Keywell to develop a startup called Tempus.

This was nothing new for the pair. They are long-time business partners who have developed multiple startups together in the past. Lefkofsky is a prominent tech founder based in Chicago who has built a fortune with his entrepreneurial spirit. Some of his startups include Groupon, Lightbank, and Uptake Technologies. He also works as an adjunct professor at the University of Chicago. In 2007 he published a book called Accelerated Disruption: Understanding the True Speed of Innovation to learn more: click here.

Lefkofsky has used his position to give back to the community. He and his wife created the Lefkofsky Family Foundation support initiatives that better the lives of the people served. Lefkofsky also serves as a Trustee for several Chicago-based organizations, including Lurie Children’s Hospital of Chicago and The Museum of Science and Industry.

Now, with Tempus, Lefkofsky is offering hope cancer community. Tempus uses data from genomic sequencing to develop the best course of treatment for each individual patient based on their specific tumors. This information helps both patients and doctors by providing them with the data they need to make informed decisions.

Tempus also has a centralized database that doctors can access. They can use the data on past cancer patients who have similarities to their current patients to see what was most effective for them. That makes Tempus a game-changer when it comes to treating cancer patients.